Avidity Partners Management LP Merus N.V. Transaction History

Avidity Partners Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$23.58 - $30.91 $2.43 Million - $3.18 Million	-103,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$20.0 - $32.29 $2.06 Million - $3.33 Million	103,000 New	103,000 $3.28 Million
Q2 2021 Aug 16, 2021	SELL	$20.0 - $25.48 $9.74 Million - $12.4 Million	-487,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$16.14 - $29.11 $7.86 Million - $14.2 Million	487,000 New	487,000 $10.2 Million

200

61.9M

243K

300K

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.28B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.